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Abstract
Background A scoring system allows risk stratification of
morbidity might be helpful for selecting risk-adapted
interventions to improve surgical safety. Few studies have
been designed to develop scoring systems to predict SSIs
after laparoscopic gastrectomy for gastric cancer.
Methods We analyzed the records of 2364 patients who
underwent laparoscopic gastrectomy for gastric cancer. A
logistic regression model was used to identify the deter-
minant variables and develop a predictive score.
Results There were 2364 patients, of whom 131 (5.5 %)
developed overall SSIs, 33 (1.4 %) developed incisional
SSIs, and 98 (4.1 %) developed organ/space SSIs. No
significant risk factor was associated with incisional SSIs.
A multivariate analysis showed the following adverse risk
factors for organ/space SSIs: BMI C 25 kg/m2, intraoper-
ative blood loss C75 ml, operation time C240 min, and
perioperative transfusion. Each of these factors contributed
1 point to the risk score. The organ/space SSIs rates were
1.8, 3.9, 9.9, and 39.0 % for the low-, intermediate-, high-,
and extremely high-risk categories, respectively
(p\ 0.001). The area under the receiver operating char-
acteristic curve for the score of organ/space SSIs was
0.734. There were no statistically significant differences
between the observed and predicted incidence rates for
organ/space SSIs in the validation set.
Conclusions This validated and simple scoring system
could accurately predict the risk of organ/space SSIs after
laparoscopic gastrectomy for gastric cancer. The score
might be helpful in the selection of risk-adapted inter-
ventions to decrease the incidence rates of organ/space
SSIs.
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Surgical site infections (SSIs) are one of the most
common nosocomial infections, accounting for
14–16 % of nosocomial infections overall and 38 % of
nosocomial infections among surgical patients [1]. SSIs
can lead to prolonged hospitalization, increased mor-
bidity and mortality, increased surgery-related costs,
and decreased quality of life [1, 2]. The incidence rates
of overall SSIs after open gastrectomy are 7.0–20.8 %
[3–6]. With an increase in the number of laparoscopic
surgeries performed in gastric cancer patients, SSIs
after laparoscopic gastrectomy have decreased com-
pared with open procedures [7], but they are still one of
the most serious concerns for surgeons and surgical
patients. Therefore, the identification of patients who
are at a high risk of SSIs might allow for the selection
of a risk-adapted laparoscopic procedure and interven-
ing perioperative measures to reduce SSIs, improve
surgical safety and patient quality of life, and achieve
the goal of being minimally invasive. The objective of
the present study was to identify the risk factors for
SSIs after a laparoscopic radical gastrectomy for gastric
cancer in 2364 patients treated in our center. We aimed
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Materials and methods
Materials
This study was a retrospective analysis of a prospectively
collected database of 2364 primary gastric cancer patients
treated with a laparoscopic radical gastrectomy in the
Department of Gastric Surgery of Fujian Medical Univer-
sity Union Hospital, Fuzhou, China, between May 2007
and Jun 2014. The inclusion criteria were as follows: a
histologically confirmed adenocarcinoma of the stomach;
no evidence of tumors invading the adjacent organs (pan-
creas, spleen, liver, and transverse colon), para-aortic
lymph node enlargement, or distant metastasis demon-
strated by abdominal computed tomography (CT) and/or
abdominal ultrasound and posteroanterior chest radio-
graphs; and a D1/D1 ? a/D1 ? b/D2 lymphadenectomy
with curative R0 according to the pathological diagnosis
after the operation. The exclusion criteria were as follows:
intraoperative evidence of peritoneal dissemination, inva-
sion into the adjacent organs, or a distant metastasis;
conversion to an open laparotomy; and incomplete patho-
logical data. All procedures were performed after obtaining
written informed consent following explanation of the
surgical and oncological risks. The patient demographics,
underlying diseases, clinicopathology, surgery data, and
data on the preoperative and postoperative monitoring were
recorded in a clinical data system for gastric cancer surgery
[8]. The staging was performed according to the 7th edition
of the UICC TNM classification [9]. The type of surgical
resection (i.e., a distal subtotal gastrectomy, proximal
subtotal gastrectomy, or total gastrectomy) and extent of
lymph node dissection were selected according to the
Japanese gastric cancer treatment guidelines [10]. Data
were randomly assigned into two subsets using the SPSS
version 18.0 (SPSS, Chicago, IL, USA), which were split
70/30: one for model development and the other for vali-
dation testing.
Variables and definitions
We defined SSIs according to the surgical patient compo-
nent of the 1999 Centers for Disease Control and Preven-
tion (CDC) National Nosocomial Infection Surveillance
(NNIS) System manual; [1] this definition includes inci-
sional (superficial, deep) and organ/space SSIs. Briefly,
superficial incisional SSIs were diagnosed within 30 days
of the operation, confined to the skin and subcutaneous
tissue, and associated with at least one of the following:
pus, microorganisms isolated from culture of fluid or tissue,
or signs or symptoms of infection. Either the surgeon or an
attending physician made the diagnosis of a superficial SSI.
A deep incisional SSI was diagnosed when the wound
infection had spread to the fascia and muscular layers, but
not the peritoneal cavity or pelvis (the organ/space), and
one of the following criteria was also present: pus origi-
nating from the deep part of the incision, spontaneous
wound dehiscence, or a wound opened by the surgeon. The
surgeon made the diagnosis of a deep infection. Organ/
space infections involved any organ or space other than an
incised layer of the abdominal wall, such as the peritoneal
cavity or pelvis.
The potential variables for SSIs were extracted from the
database, including antibiotic prophylaxis (1 g of cefazolin
was given 30\ 30 min before the incision, and an addi-
tional dose was given every 3 h during surgery), gender,
age, body mass index (BMI, BMI C 25 is considered as
overweight, according to the World Health Organization
classification [11]), previous abdominal surgery, Charlson
co-morbidity score, perioperative transfusion (transfusion
threshold Hb\ 8.0 g/dl; maintenance range 8.0–9.5 g/dl),
tumor location, tumor diameter, T stage, N stage, TNM
stage, operation time (recorded from the skin incision to
skin closure), intraoperative blood loss (estimated accord-
ing to the volume of blood absorbed by the gauze and
suction pumped after subtracting the volume of the fluids
used for irrigation), type of surgical resection, type of
reconstruction, D1/D1 ?/D2 lymphadenectomy, and
numbers of resected LNs.
Statistical analysis
The continuous data were reported as the mean ± SD, and
the differences between the groups were analyzed using
t tests. The categorical data are presented as the proportion
percentage and were analyzed with the Chi-square test or
Fisher’s exact test. The variables with p\ 0.05 in the
univariate analysis were subsequently included in a mul-
tivariate binary logistic regression model. The variables
that remained significant in the multivariate analysis were
used to construct a scoring system to classify the patients
into groups according to their risk of SSIs. A goodness-of-
fit test was conducted to assess how well the model could
discriminate between patients with and without SSIs.
Model calibration, the degree to which the observed out-
comes were similar to the outcomes predicted by the model
across patients, was examined by comparing the observed
averages with the predicted averages within each of the
subgroups arranged in increasing order of patient risk.
p\ 0.05 was considered to be statistically significant. The
statistical analyses were performed with SPSS version 18.0
(SPSS, Chicago, IL, USA).
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Results
Clinicopathological characteristics of the patients
The clinicopathological characteristics of the 2364 patients
are listed in Table 1. There were 1775 males and 589
females with a mean age of 60.93 ± 10.84 years. The
average body mass index (BMI) of the patients was
22.20 ± 3.08 kg/m2. A total gastrectomy was performed in
1264 patients (53.5 %), distal gastrectomy in 1045 patients
(44.2 %), and proximal gastrectomy in 55 patients (2.3 %);
a D1 lymphadenectomy or D1 ? lymphadenectomy was
performed in 450 patients (19.0 %) and 1 914 patients for
D2 lymphadenectomy (81.0 %); combined resection of
other organs was performed in 17 patients (nine splenec-
tomy: six for parenchymal injuries, one for splenic hilar
vascular injury, one for splenic infarction, one for hyper-
splenism; three combined cholecystectomy for gallstone;
three combined partial transverse colectomy for injuries;
and two combined partial jejunectomy for injuries). The
average surgery time was 180.86 ± 51.49 min, blood loss
was 73.50 ± 104.04 ml, and the number of dissected
lymph nodes per patient was 33.38 ± 12.96. According to
the UICC TNM Classification of Malignant Tumors, 7th
Edition, 477 patients (20.2 %) were in stage Ia, 216
(9.1 %) were in stage Ib, 242 (10.2 %) were in stage IIa,
264 (11.2 %) were in stage IIb, 239 (10.1 %) were in stage
IIIa, 374 (15.8 %) were in stage IIIb, and 552 (23.3 %)
were in stage IIIc.
Incidence and characteristics of SSIs
Of 2364 patients, intraoperative complications were
observed in 25 patients (1.1 %). Postoperative complica-
tions were observed in 330 patients (14.0 %) (Table 2),
among which SSIs (all incisional and organ/space SSIs
were grouped together) were present in 131 patients. A
total of 33 (1.4 %) patients had incisional SSIs, including
29 superficial incisional SSIs and four deep incisional SSIs.
A total of 98 (4.1 %) patients had organ/space SSIs. Thirty-
three of the 98 organ/space SSIs were intra-abdominal
abscesses due to anastomotic leakage; nine resulted from
duodenal stump fistula, five resulted from pancreatic fis-
tula, three were abscesses resulting from both pancreatic
fistula and anastomotic leakage, and the cause of organ/
space SSIs was unknown in 48 patients. Seventy-one of the
98 organ/space SSIs required anti-infection treatment, 24
required endoscopic or radiological intervention, and three
required general anesthesia during surgery (two anasto-
motic leakages and one intra-abdominal abscess). Six of
the 33 incisional SSIs only required dressing changes, 25
required anti-infection treatment, and two required
resuturing (Fig. 1). The mean lengths of the postoperative
hospital stay of patients with non-SSI were
12.30 ± 5.18 days, and of patients with overall SSIs,
superficial incisional SSIs, and organ/space SSIs were
27.69 ± 16.56, 18.27 ± 8.80, and 30.87 ± 17.37 days,
respectively. Four patients (0.2 %) died by the 30th post-
operative day. The following causes of death were noted:
intra-abdominal abscesses due to anastomotic leakage (two
patients); pancreatic fistula and anastomotic leakage (one
patient); and organ/space SSIs with unknown cause (one
patient). And by the 90th postoperative day, the deaths
added up to eight patients (0.3 %). Complications associ-
ated with SSIs were anastomotic bleeding, abdominal
bleeding, chylous leak, sepsis, pneumonia, and transient
liver enzyme abnormalities (Table 2).
Univariate and multivariate analyses associated
with the SSIs
Tables 1 and 3 show the results of the univariate and mul-
tivariate analyses of the possible risk factors for the devel-
opment of SSIs. No statistically significant factors were
associated with incisional SSIs in the univariate analyses. In
addition, five factors were associated with an increased risk
of organ/space SSIs, including the BMI (p\ 0.001),
Charlson co-morbidity score (p = 0.002), perioperative
transfusion (p\ 0.001), operation time C240 min
(p\ 0.001), and intraoperative blood loss (p\ 0.001). We
evaluated the risk factors for organ/space SSIs by multi-
variate analysis. The multivariate analysis revealed that the
following were adverse risk factors for organ/space SSIs:
BMI C 25 kg/m2 (OR = 3.638, p\ 0.001), intraoperative
blood loss C 75 ml (OR = 2.071, p = 0.010), operation
time C 240 min (OR = 3.865, p\ 0.001), and periopera-
tive transfusion (OR = 3.131, p\ 0.001).
The scoring system for organ/space SSIs
Despite the differences in the regression coefficients, which
ranged from 0.728 to 1.352 for organ/space SSIs, respec-
tively, 1 point was assigned for each of the risk factors for
simplicity. The resulting BBOT (BMI, blood loss, opera-
tion time, and transfusion) scores were built for organ/
space SSIs. Because only five of the patients had 4 points,
the following four risk groups were established: low risk (0
points, i.e., no risk factors), intermediate risk (1 point, i.e.,
one risk factor), high risk (2 points, i.e., two risk factors),
and extremely high risk (3 or 4 points, i.e., three or four
risk factors). The distribution of the patients according to
the scoring system was as follows: low risk, 59.0 %,
intermediate risk, 28.2 %, high risk, 10.3 %, and extremely
high risk, 2.5 %. The incidence rates of organ/space SSIs
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Table 1 Univariable analyses
of possible risk factors for the
development of SSIs
Variables No. patients Incisional SSIs Organ/space SSIs Overall SSIs
(n = 2364) (n = 33) p (n = 98) p (n = 131) p
Age (year) 0.810 0.344 0.481
\65 1529 22 59 81
C65 835 11 39 50
Gender 0.753 0.077 0.168
Male 1775 24 81 105
Female 589 9 17 26
ASA 0.255 0.461 0.953
B2 2276 33 93 126
[2 88 0 5 5
BMI (kg/m2) 0.390 0.000 0.000
\25 2026 30 62 92
C25 338 3 36 39
Previous abdominal surgery 0.809 0.858 0.954
Yes 347 4 15 19
None 2017 29 83 112
Charlson score 0.756 0.002 0.023
0 1652 22 59 84
1 492 5 34 39
C2 220 3 5 8
Perioperative transfusion 0.191 0.000 0.000
Yes 319 7 34 41
None 2045 26 64 90
Tumor diameter (mm) 0.406 0.698 0.930
\50 1634 25 66 91
C50 730 8 32 40
Tumor location 0.998 0.644 0.761
Upper 614 8 26 34
Middle 424 7 16 23
Lower 1034 14 40 54
C2 areas 292 4 16 20
T stage 0.603 0.877 0.939
T1 572 10 21 31
T2 286 3 11 14
T3 687 9 29 38
T4a 819 11 37 48
N stage 0.133 0.227 0.674
N0 888 15 29 44
N1 341 8 14 22
N2 382 2 22 24
N3 753 8 33 41
TNM stage 0.559 0.787 0.766
IA 477 6 17 23
IB 216 5 6 11
IIA 242 2 8 10
IIB 264 6 13 19
IIIA 239 4 11 15
IIIB 374 4 16 20
IIIC 552 6 27 33
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among the patients in the low-, intermediate-, high-, and
extremely high-risk categories were 1.8, 3.9, 9.9, and
39.0 %, respectively (p\ 0.001).The relative risks of
organ/space SSIs in the intermediate-, high-, and extremely
high-risk groups compared with the low-risk group were
2.136 (95 %CI, 1.101–4.145, p = 0.025), 5.869 (95 % CI,
2.960–11.635, p\ 0.001), and 34.027 (95 % CI,
15.570–74.360, p\ 0.001), respectively (Table 4).
Discrimination
The final models discriminated the development sets with
the areas under the receiver operating characteristic (ROC)
curve. The area under the ROC curve was 0.739
(0.669–0.808) for the logistic regression model and 0.734
(0.665–0.803) for the simplified BBOT score for organ/
space SSIs (Fig. 2). To evaluate the models’ performance,
the observed versus predicted incidence rates in the vali-
dation set were compared. The predicted incidence rates
for the low-, intermediate-, high-, and extremely high-risk
categories in the validation set were 1.9, 3.9, 10.0, and
39.0 %, respectively. There were no statistically significant
differences found between the observed and BBOT
predicted incidence rates for organ/space SSIs in the vali-
dation set (p[ 0.05) (Table 5).
Discussion
SSIs are one of the most common nosocomial infections,
and they are a fundamentally important clinical outcome
indicator in elective surgery [12–15]. Effectively decreas-
ing the incidence of SSIs is a global challenge. In 2002, the
Surgical Infection Prevention project (SIP) was initiated
under the direction of the CMS and CDC [16]. The aim of
SIP was to reduce the nationwide incidence of SSI through
systems level protocol implementation. The SIP evolved
into the Surgical Care Improvement Project (SCIP), which
was a joint effort between the CMS and Joint Commission
to further improve the nationwide compliance with stan-
dards of care in surgical practice. Some sites have
demonstrated decreased incidence of SSIs associated with
improved compliance in SCIP measures [17, 18]. However,
the incidence of SSIs has failed to decrease substantially
over time on a national scale [19, 20]. Therefore, it is
particularly important to identify and prevent the risk
factors for SSIs. The incidence rates of overall SSIs,
Table 1 continued
Variables No. patients Incisional SSIs Organ/space SSIs Overall SSIs
(n = 2364) (n = 33) p (n = 98) p (n = 131) p
Operative time (mins) 0.261 0.000 0.000
\180 1625 27 46 73
180–240 519 4 22 26
C240 220 2 30 32
IBL (ml) 0.914 0.000 0.000
\75 1917 27 55 82
C75 447 6 43 49
Surgical resection 0.546 0.061 0.186
Total 1264 16 60 76
Distal 1045 16 38 54
Proximate 55 1 0 1
Reconstruction 0.499 0.063 0.203
Roux-en-Y 1264 16 60 76
B-I 879 13 32 45
B-II 166 3 6 9
Esophagogastric 55 1 0 1
Lymphadenectomy 0.567 0.485 0.367
D1/D1? 450 5 16 21
D2 1914 28 82 110
No. of resected LNs 0.861 0.292 0.407
\33 1325 18 60 79
C33 1039 15 38 53
BMI body mass index, IBL intraoperative blood loss
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incisional SSIs, and organ/space SSIs after tradition open
gastrectomy are 7.0–20.8, 1.7–8.6, and 5.1–13.3 %,
respectively [3–6]. To the best of my knowledge, no
reports have been designed to identify the risk factors for
SSIs after a laparoscopic radical gastrectomy for gastric
cancer. In the present study, laparoscopic gastrectomy was
initially performed in patients diagnosed with cT1N0M0–
cT2N0M0 gastric cancer. With the experience accumula-
tion and expanded use of laparoscopic gastrectomy, the
indications were then gradually extended to more advanced
Table 2 Intraoperative and
postoperative morbidity







Intraoperative morbidity 25 (1.1) 3 (0.1) 2.355 (0.696–7.973) 0.168
Vascular injury 13 (0.6) 2 (0.1) 3.132 (0.687–14.277) 0.140
Spleen injury 7 (0.3) 1 (0.0) 2.855 (0.341–23.891) 0.333
Transverse colon injury 3 (0.1) 0 0 0.999
Jejunum injury 2 (0.1) 0 0 0.999
Postoperative morbidity 330 (14.0) / / /
Incisional SSIs 31 (1.3) / / /
Organ/space SSIs 98 (4.1) / / /
Anastomotic bleeding 11 (0.5) 3 (0.1) 6.519 (1.709–24.865) 0.006
Abdominal bleeding 18 (0.8) 7 (0.3)) 11.403 (4.346–29.923) 0.000
Ileus 24 (1.0) 2 (0.1) 1.558 (0.362–6.698) 0.551
Anastomotic stricture 3 (0.1) 0 0 0.999
Remnant gastric stasis 25 (1.1) 0 0 0.998
Chylous leak 21 (0.9) 7 (0.3) 8.948 (3.548–22.568) 0.000
Sepsis 5 (0.2) 4 (0.2) 70.299 (7.800–633.557) 0.000
Adhesive intestinal obstruction 1 (0.0) 0 0 0.999
Infarct of spleen 1 (0.0) 0 0 0.999
Pneumonia 137 (5.8) 35 (1.5) 7.617 (4.930–11.768) 0.000
Arrhythmia 6 (0.3) 0 0 0.999
Cardiac failure 3 (0.1) 0 0 0.999
Transient liver enzyme abnormalities 8 (0.3) 2 (0.1) 5.755 (1.150–28.792) 0.033
Urinary tract infection 11 (0.5) 2 (0.1) 3.447 (0.747–15.893) 0.113
Catheter-related infection 4 (0.2) 0 0 0.999
DIC 4 (0.2) 0 0 0.999
Cerebral infarction 1 (0.0) 0 0 0.999
SSIs surgical site infections; DIC disseminated intravascular coagulation
Fig. 1 Rates of the SSIs and the
treatments for the SSIs
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stages of disease. And the incidence rates of overall SSIs,
incisional SSIs, and organ/space SSIs after traditional open
gastrectomy were 5.5, 1.4, and 4.1 %, respectively.
Moreover, 4.1 % (4/98) of patients with organ/space SSIs
died by the 30th postoperative day. As a result, investi-
gating the risk factors for organ/space SSIs and selecting
risk-adapted interventions may help reduce the incidence
rates of organ/space SSIs.
Previous studies have reported several risk factors for
SSIs after open gastrectomy, such as advanced age, a BMI
of 25 or higher, diabetes mellitus, a longer operation
duration, blood loss, total gastrectomy, and combined
resection procedures [4, 6, 21]. However, laparoscopic
gastrectomy has its own characteristics, and the afore-
mentioned risk factors have provided limited reference
value for this procedure. And we found that the perioper-
ative transfusion, operation time C240 min, intraoperative
blood loss C75 ml, and BMI C 25 kg/m2 were the risk
factors associated with the incidence of organ/space SSIs
after laparoscopic gastrectomy. Intraoperative blood loss
requires additional hemostasis by ligation and compres-
sion, and a massive hemorrhage might lead to hypov-
olemia; these conditions appear to be associated with poor
wound healing and increased infection rates from hypoxia
[22–24]. Furthermore, the cases of preoperative anemia,
intraoperative or postoperative blood loss that require
allogeneic blood transfusion typically induce immunosup-
pression and predispose patients to postoperative infection.
Allogeneic leukocytes may play a critical role in the
induction of transfusion-induced immunosuppression [25–
28]. The operation time depends on various parameters,
such as the surgeon’s experience and technical or intra-
operative problems (e.g., accidental puncture of an intra-
abdominal organ, intraoperative hematoma, or organ
lesions). Increasing the length of the procedure theoreti-
cally increases the susceptibility of the wound by increas-
ing bacterial exposure and the extent of tissue trauma
(more extensive surgical procedure) and decreasing the
tissue level of the antibiotic [29, 30]. In addition, there is
more surrounding tissue to separate and dissect in patients
who have a high BMI. These patients typically have sig-
nificantly higher rates of SSIs as well as conversion to open
surgery and postoperative complications [6].
Few studies have been designed to create a scoring
system for predicting the risk of SSIs after an open pro-
cedure. Among these systems, the National Nosocomial
Infections Surveillance (NNIS) basic risk index is one of
the most widely used systems to predict the risk of SSIs.
The NNIS basic SSI risk index consists of the following
three criteria: American Society of Anesthesiologists score
Table 3 Multivariate analysis associated with organ/space SSIs
Variables b OR 95 % CI p
BMI C 25 kg/m2 1.291 3.638 2.135–6.199 \0.001
Operative time C 240 min 1.352 3.865 2.137–6.990 \0.001
IBL C 75 ml 0.728 2.071 1.192–3.597 0.010
Perioperative transfusion 1.141 3.131 1.798–5.450 \0.001
b regression coefficients, BMI body mass index, IBL intraoperative
blood loss
Table 4 BBOT scoring system for organ/space SSIs
Risk group BBOT score No. patients (n = 1653 %) No. patients (n %) OR 95 % CI p
Low 0 975 (59.0) 18 (1.8) 1 / /
Intermediate 1 466 (28.2) 18 (3.9) 2.136 1.101–4.145 0.025
High 2 171 (10.3) 17 (9.9) 5.869 2.960–11.635 \0.001
Extremely high C3 41 (2.5) 16 (39.0) 34.027 15.570–74.360 \0.001
BBOT, BMI, blood loss, operation time, and transfusion
Fig. 2 Receiver operating characteristic curves for prediction of
organ/space SSIs after laparoscopic gastrectomy in the development
sets
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of 3, 4, or 5; wound class; and duration of surgery.
Moreover, it has proven to be useful for risk adjustment for
many open procedures. However, Gaynes [7] also noted
that the use of a laparoscope is accompanied by signifi-
cantly lower rates of SSIs after gastric surgery, and the
NNIS basic SSI risk index might be not suitable for
laparoscopic gastrectomy. Our BBOT scoring system was
based on the final logistic regression model. With respect
to the risk stratification for organ/space SSIs, the BBOT
scoring system classified the patients after laparoscopic
gastrectomy into four groups and identified the extremely
high-risk group, which had a 23.8-fold higher risk of organ/
space SSIs than that of the lowest risk group. The BBOT
scoring system discriminated the development sets with an
area under the ROC curve of 0.734, which is similar to the
logistic regression model. There were no statistically sig-
nificant differences between the observed and BBOT
scoring system predicted incidence rates in the validation
set, indicating that this system performed well. Patient and
disease characteristic data are routinely available, which
might have implications for selecting risk-adapted inter-
ventions to improve surgical safety. Since only the BMI
can be identified preoperatively, overweight patients
(BMI C 25 kg/m2) might be referred to operators with
more experience to cut operation time and reduce blood
loss. Also, if one or more of their other risk factors occurs
intraoperatively or postoperatively, such as perioperative
transfusion, operation time C240 min, intraoperative blood
loss C75 ml, it is necessary to be aware of the sign and
symptom closely and must be examined by laboratory tests
and imageological examinations postoperatively, in order
to early detection and treatment of SSI.
Our study has some limitations. Firstly, as with other
retrospective studies, inherent selective bias is inevitable,
although we use a prospectively collected database. Sec-
ond, there are only 14.3 % patients with BMI C 25 kg/m2
in our study, whereas one-third of the US population had a
BMI of 27 kg/m2 or greater [31]. So it would seem that this
scoring system should be validated by Western centers
before applying it in Westerners.
In conclusion, our BBOT scoring system allows for easy
and validated risk stratification of the organ/space SSIs in
the clinical setting. This stratification might be helpful for
selecting risk-adapted interventions that reduce the rates of
organ/space SSIs and improve the surgical safety. A
prospective multiple-center study with a large series would
help validate this scoring system.
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